Central Nervous System Diseases  >>  levodopa/carbidopa high dose (ND0612H)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levodopa/carbidopa high dose (ND0612H) / Mitsubishi Tanabe
NCT01883505: A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612

Checkmark In Parkinson's disease
Nov 2015 - Nov 2015: In Parkinson's disease
Checkmark Preliminary results to date
Jan 2015 - Jan 2015: Preliminary results to date
Completed
2
30
RoW
Levodopa and carbidopa, Levodopa and carbidopa or saline, Placebo, Saline
NeuroDerm Ltd.
Parkinson's Disease
04/15
04/15

Download Options